期刊文献+

慢病毒载体介导人sTRAIL对胃癌SGC-7901细胞凋亡的诱导作用

Lentivirus-mediated Gene Transfer of Human sTRAIL Induced Apoptosis in SGC-7901 Cells
原文传递
导出
摘要 目的构建携带人可溶性肿瘤坏死因子相关凋亡诱导配体(sTRAIL)基因的自身失活型慢病毒载体,观察sTRAIL对人胃癌SGC-7901细胞的诱导凋亡作用,探讨其基因治疗功效。方法构建含人sTRAIL基因及内部核糖体进入位点序列(IRES)和绿色荧光蛋白(GFP)基因的双顺反子慢病毒载体。采用脂质体转染法将慢病毒三质粒包装系统包装出的携带人sTRAIL的重组慢病毒,在体外感染人胃癌SGC-7901细胞、正常人肝细胞HL-7702、人胚肺成纤维细胞HLF-1。应用流式细胞术(FCM)检测细胞凋亡率,酶联免疫吸附实验(ELISA)评价sTRAIL蛋白在胃癌细胞中的表达。结果成功构建了慢病毒表达质粒pXZ208-sTRAIL,包装的重组慢病毒滴度可达106 IU/mL,可有效感染体外培养的细胞;含sTRAIL的重组慢病毒感染SGC-7901细胞,细胞凋亡率随病毒感染复数(MOI)的增加而升高,呈剂量依赖性;在MOI为6.0、作用24h时,细胞凋亡率最高,可达(29.12±2.87)%,细胞上清中sTRAIL表达量为(34.08±3.43)ng/mL;而在HL-7702、HLF-1等人正常细胞未见明显细胞凋亡。结论含有sTRAIL基因的重组慢病毒载体在体外能够有效地感染胃癌SGC-7901细胞并使其分泌有生物活性的sTRAIL蛋白,可诱导SGC-7901细胞的凋亡,而对正常细胞无显著影响。 Objecitve To construct self-inactivating (SIN) lentiviral vector carrying human soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) gene and to observe the effects of sTRAIL gene on apoptosis in SGC-7901 cells, so as to assess the value of sTRAIL in gene therapy for gastric cancer. Methods The bicistronic SIN lentiviral transfer plasmid containing sTRAIL gene and internal ribosomal entry site-green fluorescent protein gene (IRES-GFP) was constructed. Recombinant lentivirus containing sTRAIL were packaged using liposome by lentiviral packing system. Several cell lines including HL-7702, HLF-1 and SGC-7901 cells were infected with the viral supernatant. Flow cytometry was used to measure apoptosis of cells and recombinant sTRAIL protein was assayed by EIASA at 24 h after infection. Results The lentiviral transfer plasmid pXZ208-sTRAIL was constructed, and the virus titres were above 106 IU/mL in the supernatant. SGC-7901 cells were efficiently infected by recombinant virus. The apoptosis rate of SGC-7901 cells was increased with the virus multiplicity of infection (MOI) increasing. When the MOI was ≥0.5, a dose-dependent apoptosis rate was observed. At MOI of 6.0, the highest apoptosis rate (29.12±2.87)M was observed, while the expression of sTRAIL in the supernatant was only (34.08±3. 43) ng/mL. However, no significant apoptosis was observed in HL-7702 cells and HLF-1 cells. Conclusion Recombinant lentivirus carrying human sTRAIL gene can efficiently infected SGC-7901 cells, which induced apoptosis in SGC-7901 cells in vitro by secreting bioactive sTRAIL protein. However, this effect is not seen in normal cells.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期348-351,392,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.81100349) 江苏省卫生厅青年科研课题(No.H201063)资助
关键词 慢病毒载体 可溶性肿瘤坏死因子相关凋亡诱导配体 基因治疗 Lentiviral vector Soluble tumor necrosis factor-related apoptosis-inducing ligand Genetherapy
  • 相关文献

参考文献14

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin,2011 ,61(2):69-90.
  • 2Walczak H, Haas TL. Biochemical analysis of the native TRAIl. death-inducing signaling complex. Methods Mol Biol, 2008,414:221- 239.
  • 3Corazza N, Kassahn D, Jakob S, et al. TRAIL-induced apoptosis: between tumor therapy and immunopathology. AnnN Y Acad Sci,2009,1171:50-58.
  • 4Mocellin S. Targeting death receptors to fight cancer: from biological rational to clinical implementation. Curr Med Chem, 2010 ; 17(25) : 2713-2728.
  • 5Wiezorek J, Holland P, Graves J. Death receptor agonists as a targeted therapy for cancer. Clin Cancer Res, 2010; 16 (6): 1701-1708.
  • 6侯登勇,张英起,韩苇,赵宁,颜真.TRAIL与导向肽融合基因的克隆、表达及其表达产物的生物学活性[J].中国生物制品学杂志,2005,18(4):277-280. 被引量:1
  • 7Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther, 2000 ; 7(1) : 20-23.
  • 8Wiznerowicz M, Trono D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol, 2005 ; 23 ( 1 ) : 42-47.
  • 9Kim CY, Jeong M, Mushiake H, et al. Cancer gene therapy using a novel secretable trimeric TRAIl: Gene Ther, 2006;13(4),330-338.
  • 10Xu K, Ma H, McCown T], et al. Generation of a stable cell line producing high-titer sel,inactivating lentiviral vectors. Mol Ther,2001,3(1):97-104.

二级参考文献40

  • 1张汝钢,房殿春,闫秀英,罗元辉,帖君.hTERT干扰真核表达载体的构建及鉴定[J].胃肠病学和肝病学杂志,2005,14(5):444-447. 被引量:5
  • 2冯长根,周汉生.TRAIL促肿瘤细胞凋亡的研究进展[J].中国药学杂志,2006,41(8):561-564. 被引量:9
  • 3Wiley SR, Schooley K, Stoolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis [ J ]. Immunity, 1995, 3 (6) : 673 - 382.
  • 4Trisha Gura. How TRAIL kills cancer cells, but not normal cells[J]. Science, 1997, 277(5327) :768.
  • 5Buchsbaun D J, Zhou T, Idbuguo AF. TRAIL receptor- targeted therapy[J]. Future Oncol, 2006, 2(4): 493- 508.
  • 6SchaeferU, Voloshanenko O, WilienD, et al. rrRAIL: amultifunctional cytokihe [ J ]. Front Piosci, 2007, 12 : 3813 - 3824.
  • 7CretneyE, Takeda K, Smyth MJ. Cancer:noveltherapeutic strategiesthat exploit the TNF related apoptosis - indudng ligand (TRAIL)/TRAI1 receptor pathway [ J ]. Int J Biochem Cell Piol, 2007, 39 (2) : 280 - 286.
  • 8Wu GS. TRAIL as a target in anti -cancer therapy [ J ]. Cancer Lett, 2009, 285 ( 1 ) : 1 - 5.
  • 9Yang E, Korsmeyer SJ. Molecular thonatopsis:a discourse on the Bcl -2 family and cell death[J]. Blood, 1996,88 : 386 -401.
  • 10Nencioni A, Wile L, Dal Bello G, et al. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor related apoptosis - inducing ligand in chemoresistant Bcl- 2 -overexpressing cells [ J ]. Clin Cancer Res, 2005, 11:4259 -4265.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部